|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO |
corynoxine B inhibits the reaction [manganese chloride promotes the reaction [BCL2 protein binds to BECN1 protein]] |
CTD |
PMID:30578841 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Becn1 |
beclin 1 |
multiple interactions |
ISO |
corynoxine B affects the reaction [manganese chloride affects the reaction [HMGB1 protein binds to BECN1 protein]]; corynoxine B inhibits the reaction [manganese chloride promotes the reaction [BCL2 protein binds to BECN1 protein]] |
CTD |
PMID:30578841 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
multiple interactions decreases phosphorylation |
ISO |
corynoxine B promotes the reaction [manganese chloride results in decreased phosphorylation of EIF4EBP1 protein] corynoxine B results in decreased phosphorylation of EIF4EBP1 protein |
CTD |
PMID:30578841 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Hmgb1 |
high mobility group box 1 |
multiple interactions |
ISO |
corynoxine B affects the reaction [manganese chloride affects the reaction [HMGB1 protein binds to BECN1 protein]]; corynoxine B inhibits the reaction [manganese chloride promotes the reaction [HMGB1 protein binds to SNCA protein]] |
CTD |
PMID:30578841 |
|
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions decreases phosphorylation |
ISO |
corynoxine B promotes the reaction [manganese chloride results in decreased phosphorylation of MTOR protein] corynoxine B results in decreased phosphorylation of MTOR protein |
CTD |
PMID:30578841 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
multiple interactions decreases phosphorylation |
ISO |
corynoxine B promotes the reaction [manganese chloride results in decreased phosphorylation of RPS6KB1 protein] corynoxine B results in decreased phosphorylation of RPS6KB1 protein |
CTD |
PMID:30578841 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Snca |
synuclein alpha |
multiple interactions |
ISO |
corynoxine B inhibits the reaction [manganese chloride promotes the reaction [HMGB1 protein binds to SNCA protein]] |
CTD |
PMID:30578841 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions |
ISO |
corynoxine B affects the reaction [manganese chloride affects the expression of SQSTM1 protein] |
CTD |
PMID:30578841 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
|
G |
Ccnd3 |
cyclin D3 |
decreases expression |
ISO |
lycorine results in decreased expression of CCND3 mRNA |
CTD |
PMID:23376478 |
|
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Cdh5 |
cadherin 5 |
decreases expression |
ISO |
lycorine results in decreased expression of CDH5 mRNA |
CTD |
PMID:23376478 |
|
NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
lycorine results in increased expression of CDKN1A mRNA |
CTD |
PMID:23376478 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
lycorine inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] |
CTD |
PMID:22155741 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO |
lycorine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:22155741 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
lycorine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; lycorine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] |
CTD |
PMID:22155741 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
lycorine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] |
CTD |
PMID:22155741 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Sema4d |
semaphorin 4D |
decreases expression |
ISO |
lycorine results in decreased expression of SEMA4D mRNA |
CTD |
PMID:23376478 |
|
NCBI chr17:13,430,324...13,537,146
Ensembl chr17:13,430,379...13,537,138
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions |
ISO |
lycorine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT1 protein] |
CTD |
PMID:22155741 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
lycorine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:22155741 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
lycorine inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] |
CTD |
PMID:22155741 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression |
ISO |
lycorine results in decreased expression of VEGFA mRNA |
CTD |
PMID:23376478 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one affects the reaction [[gastrodin co-treated with rhyncophylline] affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of CASP3 mRNA]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [[gastrodin co-treated with rhyncophylline] affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of CASP3 mRNA]]; [gastrodin co-treated with rhyncophylline] affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of CASP3 mRNA]; Lithium Chloride affects the reaction [[gastrodin co-treated with rhyncophylline] affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of CASP3 mRNA]] |
CTD |
PMID:33645131 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
multiple interactions |
EXP |
rhyncophylline inhibits the reaction [Amphetamine results in increased expression of GRIN2B mRNA]; rhyncophylline inhibits the reaction [Amphetamine results in increased expression of GRIN2B protein] |
CTD |
PMID:20422365 |
|
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one affects the reaction [[gastrodin co-treated with rhyncophylline] affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of HMOX1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [[gastrodin co-treated with rhyncophylline] affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of HMOX1 protein]]; [gastrodin co-treated with rhyncophylline] affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of HMOX1 protein]; Lithium Chloride affects the reaction [[gastrodin co-treated with rhyncophylline] affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of HMOX1 protein]] rhyncophylline inhibits the reaction [Paraquat results in decreased expression of HMOX1 mRNA] |
CTD |
PMID:33645131 PMID:33838153 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
rhyncophylline inhibits the reaction [4-iodo-2,5-dimethoxyphenylisopropylamine results in increased expression of and results in increased secretion of IL1B protein] |
CTD |
PMID:31231976 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
rhyncophylline inhibits the reaction [4-iodo-2,5-dimethoxyphenylisopropylamine results in increased expression of and results in increased secretion of IL6 protein] |
CTD |
PMID:31231976 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
multiple interactions |
ISO |
rhyncophylline inhibits the reaction [Paraquat results in increased phosphorylation of IRAK1 protein]; TOLLIP protein promotes the reaction [rhyncophylline inhibits the reaction [Paraquat results in increased phosphorylation of IRAK1 protein]] |
CTD |
PMID:33838153 |
|
NCBI chr X:151,768,621...151,778,521
Ensembl chr X:151,768,777...151,778,521
|
|
G |
Jak2 |
Janus kinase 2 |
multiple interactions |
EXP |
rhyncophylline inhibits the reaction [4-iodo-2,5-dimethoxyphenylisopropylamine results in increased phosphorylation of JAK2 protein] |
CTD |
PMID:31231976 |
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Lcn2 |
lipocalin 2 |
multiple interactions |
ISO |
rhyncophylline inhibits the reaction [Paraquat results in increased secretion of LCN2 protein] |
CTD |
PMID:33838153 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
rhyncophylline inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein] |
CTD |
PMID:33838153 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
EXP |
rhyncophylline inhibits the reaction [4-iodo-2,5-dimethoxyphenylisopropylamine results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:31231976 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one affects the reaction [[gastrodin co-treated with rhyncophylline] affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of NQO1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [[gastrodin co-treated with rhyncophylline] affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of NQO1 protein]]; [gastrodin co-treated with rhyncophylline] affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of NQO1 protein]; Lithium Chloride affects the reaction [[gastrodin co-treated with rhyncophylline] affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of NQO1 protein]] rhyncophylline inhibits the reaction [Paraquat results in decreased expression of NQO1 mRNA] |
CTD |
PMID:33645131 PMID:33838153 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
rhyncophylline inhibits the reaction [4-iodo-2,5-dimethoxyphenylisopropylamine results in increased phosphorylation of RELA protein] |
CTD |
PMID:31231976 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
EXP |
rhyncophylline inhibits the reaction [4-iodo-2,5-dimethoxyphenylisopropylamine results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:31231976 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
rhyncophylline inhibits the reaction [4-iodo-2,5-dimethoxyphenylisopropylamine results in increased expression of and results in increased secretion of TNF protein] |
CTD |
PMID:31231976 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tollip |
toll interacting protein |
increases expression multiple interactions |
ISO |
rhyncophylline results in increased expression of TOLLIP mRNA; rhyncophylline results in increased expression of TOLLIP protein rhyncophylline promotes the reaction [Paraquat results in increased expression of TOLLIP mRNA]; rhyncophylline promotes the reaction [Paraquat results in increased expression of TOLLIP protein]; TOLLIP protein promotes the reaction [rhyncophylline inhibits the reaction [Paraquat results in increased phosphorylation of IRAK1 protein]] |
CTD |
PMID:33838153 |
|
NCBI chr 1:196,961,585...196,984,252
Ensembl chr 1:196,950,771...196,983,625
|
|
|
G |
Arhgap36 |
Rho GTPase activating protein 36 |
decreases expression |
ISO |
securinine results in decreased expression of ARHGAP36 mRNA |
CTD |
PMID:32662633 |
|
NCBI chr X:128,780,148...128,787,169
Ensembl chr X:128,751,900...128,787,161
|
|
G |
Chga |
chromogranin A |
decreases expression |
ISO |
securinine results in decreased expression of CHGA mRNA |
CTD |
PMID:32662633 |
|
NCBI chr 6:121,696,051...121,707,399
Ensembl chr 6:121,696,051...121,707,398
|
|
G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
decreases expression |
ISO |
securinine results in decreased expression of CHRM3 mRNA |
CTD |
PMID:32662633 |
|
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
|
|
G |
Ddc |
dopa decarboxylase |
decreases expression |
ISO |
securinine results in decreased expression of DDC mRNA |
CTD |
PMID:32662633 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Eda2r |
ectodysplasin A2 receptor |
increases expression |
ISO |
securinine results in increased expression of EDA2R mRNA |
CTD |
PMID:32662633 |
|
NCBI chr X:62,224,763...62,269,333
Ensembl chr X:62,228,229...62,269,268
|
|
G |
Fat1 |
FAT atypical cadherin 1 |
increases expression |
ISO |
securinine results in increased expression of FAT1 mRNA |
CTD |
PMID:32662633 |
|
NCBI chr16:47,177,253...47,296,261
Ensembl chr16:47,177,248...47,296,107
|
|
G |
Fgf14 |
fibroblast growth factor 14 |
decreases expression |
ISO |
securinine results in decreased expression of FGF14 mRNA |
CTD |
PMID:32662633 |
|
NCBI chr15:101,045,033...101,679,888
Ensembl chr15:101,045,036...101,679,900
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
securinine results in increased expression of GCLM mRNA |
CTD |
PMID:32662633 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
securinine results in increased expression of GDF15 mRNA |
CTD |
PMID:32662633 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Hgf |
hepatocyte growth factor |
decreases expression |
ISO |
securinine results in decreased expression of HGF mRNA |
CTD |
PMID:32662633 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
increases activity |
ISO |
securinine results in increased activity of HSF1 protein |
CTD |
PMID:34170685 |
|
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
increases expression |
ISO |
securinine results in increased expression of ID1 mRNA |
CTD |
PMID:32662633 |
|
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
increases expression |
ISO |
securinine results in increased expression of ID3 mRNA |
CTD |
PMID:32662633 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Insm2 |
INSM transcriptional repressor 2 |
decreases expression |
ISO |
securinine results in decreased expression of INSM2 mRNA |
CTD |
PMID:32662633 |
|
NCBI chr 6:72,973,861...72,976,453
|
|
G |
Kif1c |
kinesin family member 1C |
increases expression |
ISO |
securinine results in increased expression of KIF1C mRNA |
CTD |
PMID:32662633 |
|
NCBI chr10:55,414,412...55,444,587
Ensembl chr10:55,415,900...55,443,545
|
|
G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
decreases expression |
ISO |
securinine results in decreased expression of MAP2K6 mRNA |
CTD |
PMID:32662633 |
|
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
securinine results in decreased expression of MYC mRNA |
CTD |
PMID:32662633 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Neurog2 |
neurogenin 2 |
decreases expression |
ISO |
securinine results in decreased expression of NEUROG2 mRNA |
CTD |
PMID:32662633 |
|
NCBI chr 2:216,092,709...216,095,276
Ensembl chr 2:216,093,363...216,094,154
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
securinine results in increased expression of NQO1 mRNA; securinine results in increased expression of NQO1 protein |
CTD |
PMID:32662633 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Pdzrn3 |
PDZ domain containing RING finger 3 |
decreases expression |
ISO |
securinine results in decreased expression of PDZRN3 mRNA |
CTD |
PMID:32662633 |
|
NCBI chr 4:133,770,736...133,996,959
Ensembl chr 4:133,770,736...133,996,959
|
|
G |
Plpp3 |
phospholipid phosphatase 3 |
decreases expression |
ISO |
securinine results in decreased expression of PLPP3 mRNA |
CTD |
PMID:32662633 |
|
NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205
|
|
G |
Rab27b |
RAB27B, member RAS oncogene family |
decreases expression |
ISO |
securinine results in decreased expression of RAB27B mRNA |
CTD |
PMID:32662633 |
|
NCBI chr18:63,597,554...63,794,124
Ensembl chr18:63,600,937...63,757,180
|
|
G |
Rnu6atac |
RNA, U6atac small nuclear |
increases expression |
ISO |
securinine results in increased expression of RNU6ATAC mRNA |
CTD |
PMID:32662633 |
|
NCBI chr 2:211,550,817...211,550,946
Ensembl chr 2:211,550,817...211,550,946
|
|
G |
Serpine1 |
serpin family E member 1 |
increases expression |
ISO |
securinine results in increased expression of SERPINE1 mRNA |
CTD |
PMID:32662633 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Serpinf1 |
serpin family F member 1 |
decreases expression |
ISO |
securinine results in decreased expression of SERPINF1 mRNA |
CTD |
PMID:32662633 |
|
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
|
|
G |
Snord72 |
small nucleolar RNA, C/D box 72 |
decreases expression |
ISO |
securinine results in decreased expression of SNORD72 mRNA |
CTD |
PMID:32662633 |
|
NCBI chr 2:54,217,160...54,217,239
Ensembl chr 2:54,217,160...54,217,239
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression |
ISO |
securinine results in increased expression of SQSTM1 mRNA |
CTD |
PMID:32662633 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
increases expression |
ISO |
securinine results in increased expression of TFPI2 mRNA |
CTD |
PMID:32662633 |
|
NCBI chr 4:31,981,786...31,986,707
Ensembl chr 4:31,982,178...31,986,600
|
|
G |
Txnip |
thioredoxin interacting protein |
decreases expression |
ISO |
securinine results in decreased expression of TXNIP mRNA |
CTD |
PMID:32662633 |
|
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
|
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
increases expression |
EXP |
Swainsonine results in increased expression of AIFM1 protein |
CTD |
PMID:33186601 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation |
ISO |
Swainsonine results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:36402259 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Atg5 |
autophagy related 5 |
multiple interactions increases expression |
ISO EXP |
[bafilomycin A1 co-treated with Swainsonine] results in increased expression of ATG5 mRNA; [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of ATG5 protein Swainsonine results in increased expression of ATG5 mRNA; Swainsonine results in increased expression of ATG5 protein |
CTD |
PMID:36402259 PMID:37442287 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atp6v1a |
ATPase H+ transporting V1 subunit A |
multiple interactions decreases expression increases expression |
EXP |
Trehalose inhibits the reaction [Swainsonine results in decreased expression of ATP6V1A protein] Swainsonine results in increased expression of ATP6V1A mRNA |
CTD |
PMID:38579922 |
|
NCBI chr11:56,561,444...56,614,694
Ensembl chr11:56,560,974...56,614,694
|
|
G |
Becn1 |
beclin 1 |
multiple interactions increases expression |
EXP ISO |
[Swainsonine co-treated with bafilomycin A1] results in increased expression of BECN1 protein Swainsonine results in increased expression of BECN1 protein Swainsonine results in increased expression of BECN1 mRNA; Swainsonine results in increased expression of BECN1 protein |
CTD |
PMID:33186601 PMID:36402259 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases cleavage |
EXP |
[Swainsonine co-treated with aloxistatin] results in increased cleavage of CASP3 protein; [Swainsonine co-treated with bafilomycin A1] results in increased cleavage of CASP3 protein Swainsonine results in increased cleavage of CASP3 protein |
CTD |
PMID:33186601 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases cleavage |
EXP |
Swainsonine results in increased cleavage of CASP8 protein |
CTD |
PMID:33186601 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases cleavage multiple interactions |
EXP |
Swainsonine results in increased cleavage of CASP9 protein [Swainsonine co-treated with Sirolimus] results in increased cleavage of CASP9 protein |
CTD |
PMID:33186601 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ctsb |
cathepsin B |
decreases expression multiple interactions increases expression |
EXP |
Swainsonine results in decreased expression of CTSB protein Trehalose inhibits the reaction [Swainsonine results in decreased expression of CTSB protein] Swainsonine results in increased expression of CTSB mRNA |
CTD |
PMID:38579922 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Ctsd |
cathepsin D |
decreases expression multiple interactions increases expression |
EXP |
Swainsonine results in decreased expression of CTSD protein [Swainsonine affects the glycosylation of CTSD protein] which results in decreased expression of CTSD protein modified form; Trehalose inhibits the reaction [Swainsonine results in decreased expression of CTSD protein] Swainsonine results in increased expression of CTSD mRNA |
CTD |
PMID:33186601 PMID:37442287 PMID:38579922 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
decreases phosphorylation |
ISO |
Swainsonine results in decreased phosphorylation of EIF4EBP1 protein |
CTD |
PMID:36402259 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Faslg |
Fas ligand |
increases expression |
EXP |
Swainsonine results in increased expression of FASLG protein |
CTD |
PMID:33186601 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Gfpt1 |
glutamine fructose-6-phosphate transaminase 1 |
decreases expression |
EXP |
Swainsonine results in decreased expression of GFAT1 protein |
CTD |
PMID:37442287 |
|
NCBI chr 4:119,496,691...119,546,472
Ensembl chr 4:119,496,714...119,546,471
|
|
G |
Lamp1 |
lysosomal-associated membrane protein 1 |
multiple interactions increases expression |
ISO |
[bafilomycin A1 co-treated with Swainsonine] results in increased expression of LAMP1 mRNA; [bafilomycin A1 co-treated with Swainsonine] results in increased expression of LAMP1 protein Swainsonine results in increased expression of LAMP1 mRNA; Swainsonine results in increased expression of LAMP1 protein |
CTD |
PMID:36402259 |
|
NCBI chr16:76,355,982...76,380,700
Ensembl chr16:76,355,984...76,381,883
|
|
G |
Lamp2 |
lysosomal-associated membrane protein 2 |
increases expression decreases expression multiple interactions |
EXP |
Swainsonine results in increased expression of LAMP2 mRNA Swainsonine results in decreased expression of LAMP2 protein Trehalose inhibits the reaction [Swainsonine results in decreased expression of LAMP2 protein] |
CTD |
PMID:38579922 |
|
NCBI chr X:117,173,097...117,222,090
Ensembl chr X:117,057,606...117,260,522
|
|
G |
Man2a1 |
mannosidase, alpha, class 2A, member 1 |
multiple interactions decreases expression |
ISO |
bafilomycin A1 inhibits the reaction [Swainsonine results in decreased expression of MAN2A1 mRNA] |
CTD |
PMID:36402259 |
|
NCBI chr 9:104,252,001...104,408,349
Ensembl chr 9:104,252,001...104,408,349
|
|
G |
Man2b1 |
mannosidase, alpha, class 2B, member 1 |
multiple interactions decreases expression |
ISO |
bafilomycin A1 inhibits the reaction [Swainsonine results in decreased expression of MAN2B1 mRNA] |
CTD |
PMID:36402259 |
|
NCBI chr19:23,055,092...23,074,398
Ensembl chr19:23,055,097...23,074,389
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions increases expression increases lipidation |
ISO EXP |
[bafilomycin A1 co-treated with Swainsonine] results in increased expression of MAP1LC3B mRNA; [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of MAP1LC3B protein Swainsonine results in increased expression of MAP1LC3B mRNA Swainsonine results in increased lipidation of MAP1LC3B protein Swainsonine results in increased localization of and results in increased lipidation of MAP1LC3B protein Swainsonine results in increased expression of MAP1LC3B protein |
CTD |
PMID:36402259 PMID:37442287 PMID:38579922 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation |
ISO |
Swainsonine results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:36402259 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation |
ISO |
Swainsonine results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:36402259 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
decreases phosphorylation |
ISO |
Swainsonine results in decreased phosphorylation of MTOR protein |
CTD |
PMID:36402259 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
decreases phosphorylation |
ISO |
Swainsonine results in decreased phosphorylation of PIK3R1 protein |
CTD |
PMID:36402259 |
|
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
decreases phosphorylation |
ISO |
Swainsonine results in decreased phosphorylation of RPS6KB1 protein |
CTD |
PMID:36402259 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression multiple interactions |
ISO EXP |
Swainsonine results in increased expression of SQSTM1 mRNA; Swainsonine results in increased expression of SQSTM1 protein [bafilomycin A1 co-treated with Swainsonine] results in increased expression of SQSTM1 mRNA; [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of SQSTM1 protein Trehalose inhibits the reaction [Swainsonine results in increased expression of SQSTM1 protein] |
CTD |
PMID:36402259 PMID:37442287 PMID:38579922 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Tfeb |
transcription factor EB |
decreases expression increases expression multiple interactions |
EXP |
Swainsonine results in decreased expression of TFEB protein Swainsonine results in increased expression of TFEB mRNA Trehalose inhibits the reaction [Swainsonine results in decreased expression of TFEB protein] |
CTD |
PMID:33186601 PMID:38579922 |
|
NCBI chr 9:13,198,890...13,254,726
Ensembl chr 9:13,198,891...13,254,714
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
ISO |
Swainsonine results in increased expression of TRP53 protein |
CTD |
PMID:36402259 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|